Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 9477 matches for

Nuffield Department of Women's & Reproductive Health sits within the Medical Sciences Division of the University of Oxford. The department encompasses multi-disciplinary research across four overarching themes; Cancer, Global Health, Maternal & Fetal Health and Reproductive Medicine & Genetics

Diagnostic test could offer new hope for ME/CFS patients

Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.

The link between childhood risk factors and adult cardiovascular events revealed

A new international study published April 4th 2022, in The New England Journal of Medicine finds, for the first time, direct evidence that the recognised risk factors for cardiovascular disease when present in childhood, predict the risk of adult cardiovascular events such as myocardial infarction and stroke.

First UK pilot study of newborn screening for spinal muscular atrophy (SMA) launched in Oxford

Spinal muscular atrophy (SMA) is a rare, but treatable, genetic disease affecting approximately 1 in 10,000 births, and it typically presents in infancy and early childhood.

Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021

Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.

Global INTERCOVID-2022 Study launched to compare Covid-19 during pregnancy, with pregnant women without the infection.

The Oxford Maternal & Perinatal Health Institute (OMPHI) has launched the 2022 round of the global study to evaluate the effects of Covid-19 variants and vaccination in pregnancy.

New guidelines launched for diagnosis and management of Endometriosis

A new comprehensive document by the European Society of Human Reproduction and Embryology (ESHRE) outlines more than 100 recommendations on best practice on caring for women with Endometriosis.

Endometriosis podcast - listen now!

In this latest podcast episode, our DPhil students Danielle Perro and Magda Mareckova, explore how surgery, psychological interventions, and other more holistic and personalised options can help manage endometriosis associated symptoms.

New Professor title awarded

Our department is celebrating a new WRH Professor! Congratulations to Prof Dagan Wells, who is awarded the full Professor title from the University of Oxford, in their annual Recognition of Distinction Exercise.

Blood pressure drugs could protect against type 2 diabetes

Lowering high blood pressure is an effective way to reduce a person’s risk of developing type 2 diabetes in the future.

AIMday in Women's Health - 22nd March 2022

The University of Oxford will be hosting an AIMday in Women’s Health on Tuesday 22nd March 2022 at St Anne's College in Oxford. This event will bring together academic excellence from across the University of Oxford together with industry to help answer the most pressing challenges in this area, as identified by industry.

Researchers identify genetic cause of endometriosis and potential drug target

Endometriosis is a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus.

Success with the Pfizer Maternal C-19 Vaccine Trial

Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.

First woman in UK receives dose of therapeutic HPV vaccine

NDWRH and Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of vaccines for the treatment and prevention of infectious diseases and cancer, see the first woman in the UK receive the first dose of a novel therapeutic HPV vaccine for the HPV001 clinical trial in Oxford.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

PhD Student of the Year Winner!

In a record breaking year for the Postgrad Awards 2021, DPhil student Tolu Awoyemi wins PhD Student of the Year. The award recognises the individual PhD student who has become an excellent and inquisitive researcher, who is an integral part of their research group, someone who encourages and supports more junior members of the team, and works alongside the research community more widely.

Pfizer Maternal C-19 Vaccine Trial Launch

The Pfizer Maternal C-19 Vaccine Trial has launched at Oxford University Hospitals NHS Foundation Trust for women between 24-34 weeks pregnant. The Nuffield Department of Women’s & Reproductive Health’s team of doctors, research midwives and nurses are delivering this critical trial to evaluate the safety, tolerability, and immunogenicity of the Pfizer vaccine in pregnant women.

A way to a woman’s heart might be through her bones

Further research into the relationship between brittle bones and women's heart disease risk could be beneficial suggest Drs Dexter Canoy and Kazem Rahimi at the Nuffield Dept of Women's & Reproductive Health.

Blood pressure medication prevents cardiovascular diseases even when blood pressure is not raised

The world's most comprehensive study of 345,000 people from 48 randomised clinical trials which revealed blood pressure-lowering medication is effective in adults, regardless of starting blood pressure level, is published in The Lancet.

Research uncovers high risk to pregnant women from COVID-19

A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.

New Endometriosis podcast launched: "Unheard of"

Listen now to the first episode ‘Unheard of – The hidden voice of Endometriosis.’ A bold new podcast series co-hosted by DPhil students Danielle Perro and Magda Mareckova, it seeks answers to the biggest questions posed by the Endometriosis community.

Load More